Total Payments
$6,681
2024 Payments
$571.54
Companies
29
Transactions
363
Medicare Patients
2,298
Medicare Billing
$209,670
Payment Breakdown by Category
Food & Beverage$6,244 (93.5%)
Education$436.73 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,244 | 351 | 93.5% |
| Education | $436.73 | 12 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $913.78 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $859.44 | 55 | $0 (2024) |
| Astellas Pharma US Inc | $676.13 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $641.36 | 34 | $0 (2024) |
| Novo Nordisk Inc | $631.31 | 32 | $0 (2024) |
| Amgen Inc. | $566.24 | 35 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $451.51 | 22 | $0 (2021) |
| Abbott Laboratories | $370.09 | 14 | $0 (2024) |
| ABBVIE INC. | $347.70 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $262.37 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $571.54 | 23 | Astellas Pharma US Inc ($182.24) |
| 2023 | $1,254 | 72 | GlaxoSmithKline, LLC. ($208.58) |
| 2022 | $912.19 | 60 | GlaxoSmithKline, LLC. ($181.62) |
| 2021 | $979.64 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($193.59) |
| 2020 | $724.60 | 42 | AstraZeneca Pharmaceuticals LP ($144.08) |
| 2019 | $811.08 | 48 | Amgen Inc. ($189.92) |
| 2018 | $1,332 | 61 | Merck Sharp & Dohme Corporation ($216.33) |
| 2017 | $95.62 | 5 | Janssen Pharmaceuticals, Inc ($33.37) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.89 | General |
| 06/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Biological | ||||||
| 05/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes Care | ||||||
| 05/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Obesity | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.99 | General |
| 04/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes Care | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Biological | ||||||
| 02/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Obesity | ||||||
| 01/31/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Obesity | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 12/21/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes Care | ||||||
| 12/19/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 702 | 1,240 | $208,252 | $67,744 |
| 2022 | 18 | 723 | 1,182 | $182,309 | $49,677 |
| 2021 | 7 | 399 | 866 | $97,234 | $52,672 |
| 2020 | 8 | 474 | 879 | $87,659 | $39,576 |
Total Patients
2,298
Total Services
4,167
Medicare Billing
$209,670
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 252 | $79,253 | $28,884 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 156 | $58,090 | $12,915 | 22.2% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 108 | $24,981 | $12,905 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $8,372 | $4,916 | 58.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 314 | $6,604 | $2,638 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 31 | $3,546 | $1,495 | 42.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 40 | 55 | $4,156 | $1,092 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 45 | $3,025 | $562.52 | 18.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 36 | 38 | $3,193 | $393.30 | 12.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 20 | 20 | $2,768 | $329.20 | 11.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 35 | 39 | $2,015 | $296.79 | 14.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 17 | 18 | $1,790 | $266.04 | 14.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 24 | 26 | $2,073 | $247.52 | 11.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 16 | 17 | $1,960 | $244.97 | 12.5% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 31 | 32 | $1,788 | $225.92 | 12.6% |
| 83550 | Iron binding capacity | Office | 2023 | 11 | 13 | $1,113 | $111.41 | 10.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 11 | 11 | $1,852 | $97.24 | 5.3% |
| 83540 | Iron level | Office | 2023 | 11 | 13 | $1,063 | $82.42 | 7.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 19 | $611.35 | $41.80 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 300 | $96,636 | $32,293 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 86 | $23,423 | $6,182 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $9,845 | $4,317 | 43.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 41 | 64 | $4,430 | $1,333 | 30.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 58 | 70 | $5,201 | $851.73 | 16.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 118 | 287 | $6,228 | $847.09 | 13.6% |
About Dr. Nanda Ramsaroop, MD
Dr. Nanda Ramsaroop, MD is a Internal Medicine healthcare provider based in Mineola, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922048032.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nanda Ramsaroop, MD has received a total of $6,681 in payments from pharmaceutical and medical device companies, with $571.54 received in 2024. These payments were reported across 363 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,244).
As a Medicare-enrolled provider, Ramsaroop has provided services to 2,298 Medicare beneficiaries, totaling 4,167 services with total Medicare billing of $209,670. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Mineola, NY
- Active Since 06/07/2006
- Last Updated 03/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922048032
Products in Payments
- TRELEGY ELLIPTA (Drug) $658.77
- FARXIGA (Drug) $634.94
- Otezla (Drug) $286.93
- JANUVIA (Drug) $259.73
- JARDIANCE (Drug) $252.26
- QULIPTA (Drug) $167.19
- XARELTO (Drug) $163.55
- Merlin Connectivity and Remote (Device) $162.56
- MYRBETRIQ (Drug) $159.61
- FREESTYLE LIBRE 3 (Device) $148.42
- Wegovy (Drug) $147.86
- ELIQUIS (Drug) $145.88
- TRADJENTA (Drug) $136.94
- STEGLATRO (Drug) $123.00
- Ozempic (Drug) $121.49
- Prolia (Biological) $106.09
- Veozah (Drug) $104.66
- Aimovig (Biological) $104.42
- INVOKANA (Drug) $98.82
- MOUNJARO (Drug) $98.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mineola
Dr. Binny Koshy, M.d, M.D
Internal Medicine — Payments: $161,926
Internal Medicine $161,926
Dr. Shilpa Desouza, Md, MD
Internal Medicine — Payments: $48,382
Internal Medicine $48,382
Dr. Dmitriy Khodorskiy, M.d, M.D
Internal Medicine — Payments: $14,203
Internal Medicine $14,203
Dr. Michael Friedman, M.d, M.D
Internal Medicine — Payments: $9,058
Internal Medicine $9,058
Anne Renteria, Md, MD
Internal Medicine — Payments: $6,591
Internal Medicine $6,591
Angela Mitrani-Schwartz, Do, DO
Internal Medicine — Payments: $6,046
Internal Medicine $6,046